Trials / Completed
CompletedNCT01116115
The Effects of Dietary Palmitic Acid Triacylglyceride Position on Intestinal Parameters in Infants (InFat_005)
The Effects of Dietary Palmitic Acid Triacylglyceride Position on Intestinal Parameters, Anthropometric Parameters and Stool Characteristics in Term Infants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Enzymotec · Industry
- Sex
- All
- Age
- 7 Days
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on intestinal parameters in term formula fed infants.
Detailed description
InFatTM is an advanced basic-fat ingredient, which mimics the fat composition and properties of human milk fat and enabling optimal intake of the essential calcium and energy (in the form of fatty acids) and easy digestion. These benefits are the result of a unique fatty acid composition on the glycerol backbone, which ensures high level of palmitic acid at the middle (sn-2) position. The purpose of this study is to determine the effect of high sn-2 palmitic acid based infant formula on intestinal parameters, anthropometric parameters and stool characteristics in formula fed term infants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | InFat™ based infant formula | High sn-2 palmitic acid oil based infant formula |
| OTHER | Standard vegetable oil based infant formula | Standard vegetable oil based infant formula |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-05-04
- Last updated
- 2011-05-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01116115. Inclusion in this directory is not an endorsement.